home.aspx
 
EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...

Alrijne Ziekenhuis

SHARESHARESHARE
What makes us Alrijne is the conviction that people get better from good care with personal attention. At our locations in Alphen aan den Rijn, Leiden and Leiderdorp we offer the best care to every patient and client. And we do this together: with patients and clients who manage their own lives, with expert and committed employees, in collaboration with general practitioners and other health care providers. With a total of 231 medical specialists and 3,857 employees, it is one of the largest employers in the region.
SHARESHARESHARE

RELATED NEWS


Verona Pharma, a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases, announces a clinical development update and interim results for the six months ended June 30, 2017. The company’s lead product candidate RPL554, is a first-in-class, inhaled, dual inhibitor of the enzymes phosphodiesterase 3 and 4, or PDE3 and PDE4, that acts as both a bronchodilator and an anti-inflammatory agent in a single compound. Verona Pharma i...

READ MORE

Researchers have developed a faster, cheaper way to coat liquid medication, an invention that could improve how drugs are delivered in the body. The new encapsulation technology, developed by engineers at the University of Waterloo, uses gravity and other natural forces to wrap drops as they fall through a thin layer of liquid shell floating on a base liquid. Once hardened, or cured, by exposure to ultraviolet light, the shell houses and protects the liquid core inside. “It is a very simpl...

READ MORE

Pfizer has announced that its investigational oral Janus kinase 1 (JAK1) inhibitor abrocitinib (PF-04965842) has met all co-primary and secondary endpoints in a pivotal Phase III study evaluating safety and efficacy in patients aged 12 and older with moderate to severe atopic dermatitis. The positive top-line results came from a randomised, double-blind, placebo-controlled, parallel-group study designed to evaluate the efficacy and safety of two doses - 100mg and 200mg once daily - of abrocitini...

READ MORE

Researchers at the Wellcome Sanger Institute have created the first comprehensive summary of all genes known to be involved in human cancer, the Cancer Gene Census. Describing all genes strongly implicated in causing cancer, the Census also describes how they function across all forms of this disease. Reported in Nature Reviews Cancer, the resource catalogs over 700 genes, to help scientists understand the causes of cancers, find drug targets and design treatments.
The study characterizes...


READ MORE

Functional (Non Ulcer) Dyspepsia - Pipeline Review, H1 2019, provides comprehensive information on the therapeutics under development for Functional (Non Ulcer) Dyspepsia (Gastrointestinal), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Fu...

BUSINESSWIRE
READ MORE

The phase 2b SHINE study of the anti-human complement factor C5a antibody was conducted in hidradenitis suppurativa (HS), a chronic inflammatory skin disease with limited treatment options that causes symptoms including inflamed nodules or boils in the armpits, groin and genital area. Unfortunately for InflaRx, the 179-patient study appears to be a near-total bust, with IFX-1 showing no improvement over placebo on symptoms after 16 weeks’ treatment. Most worryingly, there was no evidence o...

READ MORE

EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...